Autoimmune: The Cause and The Cure (This book identifies the cause & the cure for: Chronic Fatigue Syndrome, Fibromyalgia, Lupus, Rheumatoid Arthritis, Raynaud’s, Rosacea, Myasthenia Gravis, Hashimoto’s, Type 2 Diabetes, Multiple Sclerosis, Sjogren’s 1st (first) Edition by Annesse Brockley, Kristin Urdiales (2011)

 

The CalorieKing Calorie, Fat & Carbohydrate Counter 2011

Need a quick way to check calories, carbohydrates, and fat? With the more than 17,000 food listings, 200 fast-food chains, & restaurant, plus a new alcohol counter and guide, it’s easy to compare foods at a glance. Find hidden calories, fat, and carbohydrates. You’ll know which foods to avoid. Better yet, you’ll know which ones you can eat and still accomplish your weight and health goals.

 

The 2011 Report on Diabetes Monitoring Devices: World Market Segmentation by City

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market.

In performing various economic analyses for its clients, I have been occasionally asked to investigate the market potential for various products and services across cities. The purpose of the studies is to understand the density of demand within a country and the extent to which a city might be used as a point of distribution within its region. From an economic perspective, however, a city does not represent a population within rigid geographical boundaries. To an economist or strategic planner, a city represents an area of dominant influence over markets in adjacent areas. This influence varies from one industry to another, but also from one period of time to another.

In what follows, I summarize the economic potential for the world’s major cities for “diabetes monitoring devices” for the year 2011. The goal of this report is to report my findings on the real economic potential, or what an economist calls the latent demand, represented by a city when defined as an area of dominant influence. The reader needs to realize that latent demand may or may not represent real sales.

 

audio CD – Diabetes Without Drugs: The 5-Step Program (Control Blood Sugar Naturally and Prevent Diabetes Complications, 2011)

Based on breakthrough studies, Cohen’s five-step program reveals how people with diabetes can reduce their need for prescription medication and minimize the disease’s effect on the body.

Product Features

  • cd

 

CURRENT Medical Diagnosis and Treatment 2011 (LANGE CURRENT Series)

The 50th Anniversary Edition of the World’s Most Popular Annual General Medicine Book – Celebrated with a New Full-Color Design

Includes 5 online-only chapters at no additional cost at www.AccessMedicine.com/CMDT

Your first place to turn for current developments that promise better patient care

A Doody’s Core Title ESSENTIAL PURCHASE for 2011!

4 STAR DOODY’S REVIEW!
“This 50th anniversary edition brings some nice upgrades to this comprehensive book on the majority of topics that primary care physicians encounter in their offices….This book has the tremendous benefit of being updated yearly and thus has stood the test of time for recognizing what is helpful and what works. It is well worth the price and a great addition to a primary care practitioner’s library.”–Doody’s Review Service

Written by clinicians renowned in their respective fields, CMDT offers the most current insight into symptoms, signs, epidemiology, and treatment for more than 1,000 diseases and disorders. For each topic you’ll find concise, evidence-based answers to questions regarding both hospital and ambulatory medicine. This streamlined clinical companion is the fastest and easiest way to keep abreast of the latest medical advances, prevention strategies, cost-effective treatments, and more.

MORE usable patient-care information in LESS text:

  • A strong focus on the clinical diagnosis and patient management tools essential to daily practice
  • Full review of all internal medicine and primary care topics, including gynecology and obstetrics, dermatology, neurology, and ophthalmology
  • The only text with an annual review of advances in HIV treatment
  • Hundreds of drug treatment tables, with indexed trade names and updated prices – plus helpful diagnostic and treatment algorithms
  • Recent references with PMID numbers for fast access to abstracts or full-text articles
  • ICD-9 codes listed on the inside covers
  • Five online-only chapters available at no additional cost at www.AccessMedicine.com/CMDT

NEW to this edition:

  • Full-color photos and illustrations integrated with text throughout book, including much expanded dermatology and ophthalmology images
  • Newly introduced topics: E. coli O145, floppy iris syndrome, and expanded coverage of H1N1 influenza A
  • New information: emerging role for B-type natriuretic peptide (BNP) as marker of early left ventricular myocardial failure, new approaches to correction of aortic stenosis and to aortic regurgitation in Marfan syndrome, risks of typical and atypical antipsychotic medications, and new hypoglycemic agents
  • Substantial update on cardiology and hypertension, including use of stents and cardiac resynchronization therapy with biventricular pacemaker insertion, recent ACC/AHA criteria for appropriateness of coronary revascularization, use of prasugrel and clopidogrel compared with aspirin in prevention of stent thrombosis, dronedarone and catheter ablation for atrial fibrillation and dabigatran versus warfarin in prevention of atrial fibrillation-related stroke, as well as guidelines for developing an antihypertensive regimen
  • Updated information on pathogenesis and treatment of immune and drug-induced thrombocytopenia, new investigational anticoagulants such as rivaroxaban and idraparinux, risk stratification and prophylactic regimens for deep venous thrombosis and venous thromboembolism, and a prognostic model for pulmonary emboli
  • Expanded information on methicillin-resistant Staphylococcus aureus, treatment of pharyngitis and laryngitis, approaches to the diagnosis of syphilis, diagnosis and complications with borreliosis and its coinfections, acute and chronic viral hepatitides, amyloidosis, treatment and prognosis of venous stasis ulcers, and therapy for heat stroke and burns
  • Substantially updated treatment sections: HIV infections and AIDS and advances in therapy for breast cancer in women
  • Updated section on immunization requirements
  • New CMDT Online chapter on Sports Medicine and Outpatient Orthopedics

 

DietMaster 2100 Plus Nutrition Software – Low Glycemic Edition Diet Software, Awarded 2011 Best Diet Software – Top Ten Reviews

DietMaster 2100 is like having your own private nutrition counselor! Enter your personal profile to calculate your calorie needs and select from ready-to-print low glycemic meal plans and grocery lists designed by our team of registered dietitians. DietMaster 2100 also provides you the ability to analyze your eating habits to identify caloric intake and nutrient deficiencies.

Set your goal weight and estimate the date you will reach your goal. Track your body symmetry measurements including arms, shoulders, waist, hips, thighs and more. Use the Body Composition screen to save historical body weight and body fat data and graph progress over 3 months, six months or one year.

** A note from our Registered Dietitan about the meal plans included in this porgram: These menus will help you follow a diet that contains low glycemic foods. Most of the foods contained in these menus have a glycemic index of around 50 or less. Following a diet full of lower glycemic foods can help keep your blood sugar level from falling too rapidly. Low glycemic foods do not cause your body to release as much insulin into your bloodstream and as a result are broken down over a longer period of time. The result is a longer, steadier release of energy, helping you to feel more alert and energetic through your day.

The new DietMaster 2100 Plus edition includes a Fitness Assessment Module for evaluating ones overall fitness condition including cardiovascular, flexibility, strength and body composition.

IMPORTANT: DietMaster 2100 Plus editions are not designed for professional use. Certain personal profile information cannot be changed once entered (e.g., birth date and gender). DietMaster 2100 and other DietMaster products are not intended to replace the expert advice of a medical practitioner and are not designed to treat diseases of any kind.

Product Features

  • Loaded with ready-to-print low glycemic meal plans & grocery lists designed by our Registered Dietitian.
  • Log food intake and log exercise to calculate calorie consumed vs. burned.
  • Food database contains 13,000 selections including fast foods and coffee, or add your favorites.
  • Keep track of body symmetry measurements, body weight and body fat.
  • Rank and track your overall fitness condition with the Fitness Assessment Module.

 

Diabetic Macular Edema – Pipeline Review, H2 2011

Diabetic Macular Edema – Pipeline Review, H2 2011

Summary

Global Markets Direct’s, ‘Diabetic Macular Edema – Pipeline Review, H2 2011’, provides an overview of the Diabetic Macular Edema therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Macular Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Macular Edema. ‘Diabetic Macular Edema – Pipeline Review, H2 2011’ is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • A snapshot of the global therapeutic scenario for Diabetic Macular Edema.
  • A review of the Diabetic Macular Edema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Diabetic Macular Edema pipeline on the basis of route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Identify and understand important and diverse types of therapeutics under development for Diabetic Macular Edema.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Diabetic Macular Edema pipeline depth and focus of Diabetic Macular Edema therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

 

Diabetic Gastroparesis – Pipeline Review, Q1 2011

Diabetic Gastroparesis – Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, ‘Diabetic Gastroparesis – Pipeline Review, Q1 2011’, provides an overview of the Diabetic Gastroparesis therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Gastroparesis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Gastroparesis. ‘Diabetic Gastroparesis – Pipeline Review, Q1 2011’ is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

  • A snapshot of the global therapeutic scenario for Diabetic Gastroparesis.
  • A review of the Diabetic Gastroparesis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Diabetic Gastroparesis pipeline on the basis of therapeutic class, route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Identify and understand important and diverse types of therapeutics under development for Diabetic Gastroparesis.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Diabetic Gastroparesis pipeline depth and focus of Diabetic Gastroparesis therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

 

DietMaster 2100 Plus Nutrition Software – Stable Blood Sugar Edition Diet Software, Awarded 2011 Best Diet Software – Top Ten Reviews

DietMaster 2100 V8 is like having your own private sports nutrition counselor! Enter your personal profile to calculate your calorie needs and select from ready-to-print stable blood sugar meal plans and grocery lists designed by our team registered dietitians. DietMaster 2100 also provides you the ability to analyze your eating habits to identify caloric intake and nutrient deficiencies.

Set you goal weight and track your body symmetry measurements including arms, shoulders, waist, hips, thighs and more. Use the Body Composition screen to save historical body weight and body fat data and graph progress over 3 months, six months or one year.

Dietitians note about meal plans included in the software: Blood sugar or glucose is the body’s main source of energy and is formed when any type of carbohydrate is digested. Keeping blood sugar levels stable or level throughout the day is vital to people with diabetes to help protect them from developing diabetic complications down the road. Tight control of blood sugar levels can also help you avoid hunger throughout the day. The Templates incorporate six meals everyday to help minimize dips in blood sugar levels. They are packed with good nutrition including fiber, healthy fats, flaxseed and chromium that all play an important role in stabilizing blood sugar levels. If you have type 1 or type 2 diabetes, check with your physician before following any type of meal plan. Meal planning for diabetics should be individualized and based on individual nutritional goals as well as medications.

IMPORTANT: DietMaster 2100 Plus editions are not designed for professional use. Certain personal profile information cannot be changed once entered (e.g., birth date and gender). DietMaster 2100 and other DietMaster products are not intended to replace the expert advice of a medical practitioner and are not designed to treat diseases of any kind.

Product Features

  • Loaded with ready-to-print stable blood sugar meal plans & grocery lists designed by a Registered Dietitian.
  • Log food intake and log exercise to calculate calorie consumed vs. burned.
  • Food database contains 13,000 selections including fast foods and coffee, or add your favorites.
  • Keep track of body symmetry measurements, body weight and body fat.
  • Rank and track your overall fitness condition with the Fitness Assessment Module

 

Go Top